These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2265473

  • 1. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters.
    Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA.
    Carcinogenesis; 1990 Dec; 11(12):2223-6. PubMed ID: 2265473
    [Abstract] [Full Text] [Related]

  • 2. Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA.
    Cancer Lett; 1991 Jul 26; 59(1):45-50. PubMed ID: 1878860
    [Abstract] [Full Text] [Related]

  • 3. Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model.
    Pour PM, Lawson T, Helgeson S, Donnelly T, Stepan K.
    Carcinogenesis; 1988 Apr 26; 9(4):597-601. PubMed ID: 2833367
    [Abstract] [Full Text] [Related]

  • 4. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M, van Garderen-Hoetmer A, Lamers CB, Rovati LC, Jansen JB, Woutersen RA.
    Cancer Lett; 1991 Dec 01; 60(3):205-11. PubMed ID: 1756510
    [Abstract] [Full Text] [Related]

  • 5. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK, Permert J, Kazakoff KR, Pour PM, Zuker KA, Bilchik AJ, Adrian TE.
    Carcinogenesis; 1993 May 01; 14(5):1021-6. PubMed ID: 7684953
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancing effects of quinacrine on development of hepatopancreatic lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters.
    Furukawa F, Nishikawa A, Imazawa T, Kasahara K, Takahashi M.
    Jpn J Cancer Res; 1998 Feb 01; 89(2):131-6. PubMed ID: 9548439
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of 3-aminobenzamide on the post-initiation phase of N-nitrosobis(2-oxopropyl)amine induced pancreatic carcinogenesis in Syrian hamsters.
    Tsujiuchi T, Mizumoto K, Tsutsumi M, Denda A, Amanuma T, Kondoh S, Konishi Y.
    Cancer Lett; 1991 Dec 09; 61(1):61-6. PubMed ID: 1764698
    [Abstract] [Full Text] [Related]

  • 19. Effect of streptozotocin diabetes on development of nitrosamine-induced pancreatic carcinoma when diabetes induction occurs after nitrosamine exposure.
    Povoski SP, Fenoglio-Preiser CM, Sayers HJ, McCullough PJ, Zhou W, Bell RH.
    Carcinogenesis; 1993 May 09; 14(5):961-7. PubMed ID: 8504490
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.